An Investor Consortium completed the acquisition of a majority stake in DETAX.

An Investor Consortium, includes ECM Equity Capital, PINOVA Capital and Gilde Healthcare Private Equity, completed the acquisition of a majority stake in DETAX, a supplier of polymer materials for medical applications. Financial terns were not disclosed. “DETAX is an exceptionally attractive company. We are excited about the highly professional organization, led by a high-calibre, experienced and motivated management team, the strong market positioning as well as the excellent reputation of the group as a leading specialist for medical materials. We are extremely pleased to accompany DETAX’s successful growth trajectory in partnership with the management team,” Tim Krume, ECM Director.